https://www.zacks.com/stock/news/2229453/charles-river-crl-gains-from-cradl-amid-soft-market-scenario?cid=CS-ZC-FT-analyst_blog|zer_report_update-2229453
Feb 21, 2024 - Within DSA, Charles River (CRL) is currently the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
zc:-1687048705022225755
0
https://www.zacks.com/stock/news/2229514/here-s-why-you-should-retain-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2229514
Feb 21, 2024 - Investors are optimistic about Align Technology (ALGN) on continued geographic expansion.
zc:-2092168300853903911
0
https://www.zacks.com/stock/news/2230458/icon-iclr-q4-earnings-surpass-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2230458
Feb 22, 2024 - ICON's (ICLR) solid performance in the fourth quarter reflects continued market leadership across customer segments it serves.
zc:-4471981085210441560
0
https://www.zacks.com/stock/news/2231893/here-s-why-you-should-buy-edward-lifesciences-ew-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2231893
Feb 26, 2024 - Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.
zc:-2662122675367703698
0
https://www.zacks.com/stock/news/2232652/quest-diagnostics-dgx-new-pact-to-reduce-food-insecurity?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2232652
Feb 27, 2024 - Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
zc:-810626733911373088
0
https://www.zacks.com/stock/news/2234635/myriad-genetics-mygn-to-evaluate-mrd-testing-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2234635
Mar 01, 2024 - Myriad Genetics' (MYGN) MRD test is uniquely capable of detecting ctDNA at the lowest levels of detection, which is essential for a pan-cancer investigation.
zc:-110463571899944335
0
https://www.zacks.com/stock/news/2237419/phibro-pahc-appears-well-poised-on-launches-vaccine-sales?cid=CS-ZC-FT-analyst_blog|zer_report_update-2237419
Mar 07, 2024 - Phibro (PAHC) is focusing on new developments along with incremental registrations and growing volumes of existing nutritional specialties and vaccine technologies.
zc:-7444438580819497867
0
https://www.zacks.com/stock/news/2238699/here-s-why-you-should-retain-teleflex-tfx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2238699
Mar 11, 2024 - Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
zc:3572943461378206867
0
https://www.zacks.com/stock/news/2238707/thermo-fisher-tmo-unveils-corevitas-clinical-registry-in-gpp?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238707
Mar 11, 2024 - Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.
zc:-7691579945408395418
0
https://www.zacks.com/stock/news/2240756/inspira-technologies-iinn-releases-favorable-data-on-vortx?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240756
Mar 14, 2024 - Inspira Technologies' (IINN) proprietary orbiting oxygenation technology eliminates the need for membrane fibers, thereby reducing pressure differentials and high shear stress.
zc:-167743009412675318
0